Boston Scientific and Coloplast—the two remaining U.S. manufacturers of transvaginal surgical mesh—have been ordered by the FDA to halt the sale and distribution of those products across the country, ...
CHICAGO — The ban on further sales of transvaginal mesh for pelvic organ prolapse (POP) imposed by the US Food and Drug Administration (FDA) last month has some people cheering, some saying that an ...
Johnson & Johnson and its Ethicon division have reached a deal with the attorneys general of 41 states and the District of Columbia, agreeing to settle claims that it deceptively advertised and ...
October 21, 2008 — Clinicians should receive specialized training for the transvaginal placement of mesh products and be vigilant for adverse events, the US Food and Drug Administration (FDA) warned ...
FDA: Serious Complications Associated With Surgical Mesh for Transvaginal Repair of POP are Not Rare
The U.S. Food and Drug Administration has issued an update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse (POP), indicating these ...
Coloplast was informed yesterday by the FDA that the PMA for Restorelle DirectFix Anterior is not approved and the company must cease marketing and distribution immediately. As a result, FDA ...
Add Yahoo as a preferred source to see more of our stories on Google. Surgical mesh implants used to treat women's pelvic organ problems are being removed from the Canadian market following a safety ...
Transvaginally placed surgical mesh may pose greater safety risks for women with pelvic organ prolapse (POP) undergoing reconstructive surgery than other surgical options — without evidence of greater ...
WASHINGTON (CN) - As reports of serious complications continue to rise, the Food and Drug Administration has issued two orders to manufacturers to strengthen requirements for transvaginal surgical ...
Johnson & Johnson, a global healthcare giant based in New Brunswick, New Jersey, lost a product liability lawsuit surrounding its transvaginal mesh implants manufactured by Ethicon, a subsidiary of ...
Please provide your email address to receive an email when new articles are posted on . Transvaginal mesh was noninferior to native tissue repair in women with pelvic organ prolapse at 36 months, ...
WILMINGTON, Del. -- A Delaware jury has ordered a medical device manufacturer to pay $100 million to a woman who, despite two surgeries, still has pieces of transvaginal mesh embedded inside her. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results